Transparency Market Research (TMR) has published a new report titled, ‘Tuberculosis Testing Market -
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’. According to the
report, the global Tuberculosis Testing Market was valued at US$ 2,468.5 Mn in 2018 and is projected to
expand at a CAGR of 4.0% from 2019 to 2027.
Tuberculosis is a disease caused by germs which spread from person to person through the air.
Tuberculosis usually affects the lungs, but it can also affect other parts of the body, such as the
brain, the kidneys, or the spine.
When someone who is sick with Tuberculosis coughs, speaks, laughs, sings, or sneezes, people
nearby may breathe Tuberculosis bacteria into their lungs. Tuberculosis bacteria can live in the
body without making a person sick. This is called latent Tuberculosis infection. People with
latent Tuberculosis infection do not feel sick, do not have Tuberculosis symptoms, and cannot
spread Tuberculosis bacteria to others.
North America dominated the global Tuberculosis Testing Market in 2018 and the trend is
anticipated to continue during the forecast period. Highly structured health care industry, and
introduction of the Affordable Care Act in the U.S. are expected to drive the market in North
Asia Pacific is likely to be a highly lucrative market for tuberculosis and it is expected to expand
at a high CAGR during the forecast period.
Request Brochure of Report -
Rising demand for improved and technologically advanced tuberculosis testing procedures to Drive
New, improved, and technologically advanced TB testing techniques such as IGRA, rapid TB
tests, and serological tests have made the diagnosis more accurate, reliable, quick, and easy
Improvements in culture-based tests by using liquid culture mediums as well as drug
susceptibility and drug sensitivity testing over culture media have led to increase in the demand